REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,951 | -26.3% | 21,505 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $499,346 | +15.1% | 21,505 | -12.5% | 0.00% | +33.3% |
| Q1 2023 | $433,977 | -26.2% | 24,574 | +13.6% | 0.00% | -40.0% |
| Q4 2022 | $588,227 | +57.5% | 21,626 | 0.0% | 0.01% | +66.7% |
| Q3 2022 | $373,481 | +40.5% | 21,626 | +42.2% | 0.00% | +50.0% |
| Q2 2022 | $265,853 | +2.9% | 15,209 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $258,249 | -3.4% | 15,209 | +54.2% | 0.00% | 0.0% |
| Q4 2021 | $267,342 | -8.6% | 9,865 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $292,399 | -22.9% | 9,865 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $379,013 | +25.9% | 9,865 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $300,981 | -20.0% | 9,865 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $376,350 | +65.7% | 9,865 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $227,092 | -7.4% | 9,865 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $245,145 | – | 9,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |